
0:00
28:53
Andre Bessette is the CEO of Eclipse Regenesis, a company developing a mechanical solution to short bowel syndrome. In this episode, Andre highlights the regulatory pathways available to solutions addressing needs in small patient populations. He also discusses clinical study site selection, payor engagement, and the current challenges of short bowel syndrome and necrotizing enterocolitis care.
Otros episodios de "Impact1 Voices"



No te pierdas ningún episodio de “Impact1 Voices”. Síguelo en la aplicación gratuita de GetPodcast.








